Cargando…

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study

OBJECTIVES: To compare the efficacy and tolerability of losartan, telmisartan, and olmesartan as antihypertensive agents and evaluate and compare their effects on lipid profile and blood glucose. MATERIALS AND METHODS: This was a randomized, open-label, parallel-group, comparative study conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalikar, Mrunalini, Nivangune, Kundan S., Dakhale, Ganesh N., Bajait, Chaitali S., Sontakke, Smita D., Motghare, Vijay M., Budania, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642122/ https://www.ncbi.nlm.nih.gov/pubmed/29081617 http://dx.doi.org/10.4103/jpp.JPP_39_17

Ejemplares similares

Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study
por: Kadam, Renuka L., et al.
Publicado: (2020)

Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial
por: Shinde, Viraj Ashok, et al.
Publicado: (2017)

Evaluation of adherence to therapy in patients of chronic kidney disease
por: Sontakke, Smita, et al.
Publicado: (2015)

Assessment of adherence to medication during chronic illnesses in pregnancy
por: Sontakke, Smita, et al.
Publicado: (2021)

Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital
por: Pimpalkhute, Sonali A., et al.
Publicado: (2015)

Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study
por: Dakhale, Ganesh N., et al.
Publicado: (2019)

Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study
por: Dakhale, Ganesh N., et al.
Publicado: (2021)

Effect of educational intervention on awareness of pharmacovigilance among medical undergraduates in a tertiary care teaching hospital
por: Kalikar, Mrunalini V., et al.
Publicado: (2020)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
por: Kalikar, Mrunalini V., et al.
Publicado: (2022)

Analysis of serious adverse events reports: Review by an Institutional Ethics Committee of a tertiary care teaching hospital
por: Dakhale, Ganesh Nathuji, et al.
Publicado: (2022)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders
por: Bajait, Chaitali S, et al.
Publicado: (2014)

Role of zinc in pediatric diarrhea
por: Bajait, Chaitali, et al.
Publicado: (2011)

Authors’ reply
por: Bajait, Chaitali, et al.
Publicado: (2012)

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension
por: Aydoğan, Berna İ, et al.
Publicado: (2019)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis
por: Kumari, Kusum, et al.
Publicado: (2022)

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
por: Mandavdhare, Harshal Surendra, et al.
Publicado: (2017)

Assessment of knowledge, attitude and practice towards COVID-19 among paramedical staff in Central India: A cross-sectional, online survey
por: Chindhalore, Chaitali Ashish, et al.
Publicado: (2021)

Telmisartan, when compared to losartan, shows additional beneficial effects to pancreatic islet structure and function in diet-induced obese mice
por: Graus-Nunes, Francielle, et al.
Publicado: (2015)

Comparison of self-medication practices with analgesics among undergraduate medical and paramedical students of a tertiary care teaching institute in Central India – A questionnaire-based study
por: Chindhalore, Chaitali Ashish, et al.
Publicado: (2020)

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
por: Chrysant, S G, et al.
Publicado: (2010)

Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
por: Gao, Pingjin, et al.
Publicado: (2015)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers()
por: Li, Kun-Yan, et al.
Publicado: (2014)

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
por: Rothlin, Rodolfo Pedro, et al.
Publicado: (2023)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Akat, Pramod B., et al.
Publicado: (2010)

Pidotimod: In-depth review of current evidence
por: Mahashur, Ashok, et al.
Publicado: (2019)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
por: Bramlage, Peter, et al.
Publicado: (2010)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lv75qjf270470te1mmpj4pq1l2